Related Experiment Video
Updated: Jan 11, 2026

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
Published on: April 10, 2015
The effect of ancillary ligands on vasodilatory activity of nitrosyl ruthenium complexes
Iury A Paz1, Carlos D S Silva2, Edinilton M Carvalho3
1Group of Bioinorganic, Department of Organic and Inorganic Chemistry, Federal University of Ceará, PO Box 6021, Fortaleza 60440-900, Brazil; Department of Physiology and Pharmacology, Superior Institute of Biomedical Sciences, State University of Ceará, 1700. Dr Silas Munguba Av, Fortaleza 60455-900, Ceará, Brazil.
Abstract:
Sodium nitroprusside (Na2[Fe(CN)5NO], SNP) has long been administered in emergencies to reduce the blood pressure of cardiovascular patients. Despite resolution, NO rapid release and the toxicity of cyanide associated with SNP cause substantial harm. This study investigated three nitrosyl ruthenium complexes for vasodilatory activity, focusing on controlled NO release from a non-toxic compound. Cis-[Ru(bpy)2(5-ain)NO](PF6)3 (5-ainBpy), cis-[Ru(phen)2(5-ain)NO](PF6)3 (5-ainPhen), and cis-[Ru(phen)2(SO3)NO]PF6 (SO3Phen), where bpy = 2,2'-bipyridine, phen = 1,10-phenantroline, and 5-ain = 5-azaindole, were fully characterized by electrochemical and spectroscopic techniques, and showed no toxicity against rat cardiomyoblast (H9c2) and murine fibroblast cells (L929). Vasodilatory assays were conducted on pre-contracted rat thoracic aortic rings using SNP as reference compound. All complexes exhibited efficacies comparable to SNP (from 134 to 146 %), yet only SO3Phen showed a 160-fold lower potency, suggesting that the ancillary ligand 5-azaindole exerts a stronger influence. Kinetic data showed that the maximum efficacy of the vasodilatory activity is reached by 5-ainBpy and 5-ainPhen after 15 and 23 min, respectively, while just 1 min is needed for SNP. For the sulfite complex, only 65 % of relaxation was achieved after 30 min. The results suggest that the vasodilatory activity of the studied complexes is associated with the easiness and rate of the NO release which, in turn, is strongly dependent on the chemical nature of the ancillary ligands occupying the cis position to NO. Current experiments with complexes containing ligands of varying π Lewis acid strength in the cis position to NO are being conducted to further validate the proposed hypothesis.
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
EDTA: Auxiliary Complexing Reagents
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Complexation Equilibria: The Chelate Effect
Nitric Oxide Signaling Pathway

